Bambusa Therapeutics

News

2026's sizeable haul of IPOs shows no signs of letting up, with three more biotechs – Bambusa, Aspen, and blank cheque firm Tang – joining the queue.

News

Roche has added to its weight-loss drug pipeline again, turning to China's Rona Therapeutics for an RNAi candidate targeting ALK7.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.